Hplc Methods for Quantifying Anticancer Drugs in Human Samples: A Systematic Review Publisher Pubmed



Sabourian R^{1, 2} ; Mirjalili SZ^{1, 2} ; Namini N¹ ; Chavoshy F¹ ; Hajimahmoodi M¹ ; Safavi M³ Show Affiliations
Source: Analytical Biochemistry Published:2020

Abstract

Pharmacokinetic (PK) study of anticancer drugs in cancer patients is highly crucial for dose selection and dosing intervals in clinical applications. Once an anticancer drug is administered, it undergoes various metabolic pathways; to determine these pathways, it is necessary to follow the administered drug in biological samples via different analytical methods. In addition, multi-drug quantification methods in patients undergoing multi-drug regimens of cancer therapy can have several benefits, such as reduced sampling time and analysis costs. In order to collect and categorize these studies, we conducted a systematic review of HPLC methods reported for the analysis of anticancer drugs in biological samples. A systematic search was performed on PubMed Medline, Scopus, and Web of Science databases, and 116 studies were included. In summary of included studies, when the objective of a method was to quantify a single drug, MS, or UV detectors were utilized equivalently. On the other hand, in methods with the aim of quantifying drug and metabolite(s) in a single run, MS detectors were the most utilized. This review can provide a comprehensive insight for researchers prior to developing a quantification method and selecting a detector. © 2020 Elsevier Inc.